Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 3 October 2006. doi:10.1136/jcp.2005.032839
Journal of Clinical Pathology 2007;60:804-807
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

ORIGINAL ARTICLE

Expression of c-kit in human osteosarcoma and its relevance as a prognostic marker

Irene Sulzbacher1, Peter Birner1, Cyril Toma2, Nikolaus Wick1 and Peter R Mazal1

1 Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria
2 Department of Orthopaedics, Medical University of Vienna, Vienna, Austria

Correspondence to:
Correspondence to:
Dr Irene Sulzbacher
Clinical Institute of Pathology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria; irene. sulzbacher{at}meduniwien.ac.at

Aims: To examine the prognostic relevance of c-kit expression in human osteosarcomas and to evaluate the mutation status in exon 9 and exon 11 of the c-kit gene.

Methods: c-kit expression was examined in 100 human osteosarcomas by immunohistochemistry using paraffin embedded tumour tissues, and capillary sequencing of genomic DNA was performed to search for mutations in exons 9 and 11 of the c-kit gene.

Results: 20 osteosarcomas showed c-kit expression ranging from 5% to 90% (mean 5.9%; SD 16.74%). Furthermore, DNA sequences of exon 9 and exon 11 of the c-kit gene were not altered in these tumours. Overall and disease free survival analysis did not reveal any differences between patients with osteosarcoma with c-kit expression and those with c-kit negative tumours.

Conclusions: C-kit expression is not a prognostic marker in patients with osteosarcoma. The protein expression is not linked to mutations in exon 9 or exon 11 of the c-kit gene. Therefore, these exons may not function as targets for treatment modalities based on the suppression of c-kit tyrosine kinase activity.

Abbreviations: GIST, gastrointestinal stroma tumour; PDGF, platelet derived growth factor; PDGFRA, platelet derived growth factor receptor alpha

Keywords: osteosarcoma; c-kit; prognosis; mutation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs